Differential action of a protein tyrosine kinase inhibitor, genistein, on the positive inotropic effect of endothelin‐1 and norepinephrine in canine ventricular myocardium
Differential action of a protein tyrosine kinase inhibitor, genistein, on the positive inotropic effect of endothelin‐1 and norepinephrine in canine ventricular myocardium
复制标题
DOI:
10.1038/sj.bjp.0706097
复制
发表时间:
2005-02
影响因子:
7.3
通讯作者:
L. Chu;Jian-xin Zhang;I. Norota;M. Endoh
中科院分区:
文献类型:
--
作者:
L. Chu;Jian-xin Zhang;I. Norota;M. Endoh
1Experiments were carried out in isolated canine ventricular trabeculae and acetoxymethylester of indo‐1‐loaded single myocytes to elucidate the role of protein tyrosine kinase (PTK) in the inotropic effect of endothelin‐1 (ET‐1) induced by crosstalk with norepinephrine (NE). The PTK inhibitor genistein was used as a pharmacological tool.2Genistein but not daidzein inhibited the positive inotropic effect and the increase in Ca2+transients induced by ET‐1 by crosstalk with NE at low concentrations.3Genistein and daidzein antagonized the negative inotropic effect and the decrease in Ca2+transients induced by ET‐1 by crosstalk with NE at high concentrations, but genistein did not affect the antiadrenergic effect of carbachol.4Genistein but not daidzein enhanced the positive inotropic effect and the increase in Ca2+transients induced by NEvia β‐adrenoceptors, while the enhancing effect of genistein was abolished by the protein tyrosine phosphatase inhibitor vanadate.5These findings indicate that genistein (1) induces a positive inotropic effect in association with an increase in Ca2+transients, (2) inhibits the positive inotropic effect of ET‐1 induced by crosstalk with NE, and (3) enhances the positive inotropic effect of NE inducedvia β‐adrenoceptors by inhibition of PTK. In addition, genistein inhibits the negative inotropic effect of ET‐1 induced by crosstalk with NE through a PTK‐unrelated mechanism. PTK may play a crucial role in the receptor‐mediated regulation of cardiac contractile function in canine ventricular myocardium.British Journal of Pharmacology(2005)144, 430–442. doi:10.1038/sj.bjp.0706097